Residual Vein Thrombosis and D-Dimer for Optimizing Duration of Anticoagulation in Idiopathic Deep Vein Thrombosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|31|3483-3486

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.31, 2010-10, pp. : 3483-3486

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment options for deep vein thrombosis

By Squizzato Alessandro   Dentali Francesco   Ageno Walter  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 7, 2010-05 ,pp. : 1069-1075

Informa Healthcare

Access to resources Recommend Favorite

Thalidomide: Deep vein thrombosis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1260, 2009-01 ,pp. : 29-29

Adis International

Access to resources Recommend Favorite

Current Management of Acute Symptomatic Deep Vein Thrombosis

By Heit J.A.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 1, 2001-01 ,pp. : 45-50

Adis International

Access to resources Recommend Favorite

Current pharmacotherapeutic options for treating deep vein thrombosis

By Merli Geno J  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 1, 2003-01 ,pp. : 55-65

Informa Healthcare

Access to resources Recommend Favorite

Celecoxib: Deep vein thrombosis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1058, 2005-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite